CYTKCytokinetics

$13.94
$0.00 (0%)

Cytokinetics (CYTK) Stock Analysis

Create a FREE Account to View Full CYTK Stock Report

Cytokinetics (CYTK) Analyst Forecast

Next 12 months ➝Current Price$13.9452-week High$16.9652-week Low$5.75MEAN$21.50+54.29%HIGH$30.00+115.29%LOW$14.00+0.47%
  • Last Price$13.94
  • Previous Close$13.94
  • Change $0.00
  • Open$13.25
  • Volume1,048,930
  • Avg. Volume (100-day)867,432
  • Market Capitalization$824.41M
  • Days Range $13.11 - $14.40
  • 52-week Range $5.75 - $16.96
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-2.08
  • Earnings Date03/03/2020
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta0.93
  • PEG Ratio
  • Volatility0.78
  • Average True Range0.05
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.